BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36845099)

  • 1. Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature.
    Uhl B; Haring F; Slotta-Huspenina J; Luft J; Schneewind V; Hildinger J; Wu Z; Steiger K; Smiljanov B; Batcha AMN; Keppler OT; Hellmuth JC; Lahmer T; Stock K; Weiss BG; Canis M; Stark K; Bromberger T; Moser M; Schulz C; Weichert W; Zuchtriegel G; Reichel CA
    Front Immunol; 2023; 14():1078005. PubMed ID: 36845099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitronectin stabilizes intravascular adhesion of neutrophils by coordinating β2 integrin clustering.
    Zuchtriegel G; Uhl B; Pick R; Ramsauer M; Dominik J; Mittmann LA; Canis M; Kanse S; Sperandio M; Krombach F; Reichel CA
    Haematologica; 2021 Oct; 106(10):2641-2653. PubMed ID: 32703799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitronectin binds to activated human platelets and plays a role in platelet aggregation.
    Asch E; Podack E
    J Clin Invest; 1990 May; 85(5):1372-8. PubMed ID: 1692034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
    Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
    Mousa SA; Khurana S; Forsythe MS
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.
    Coller BS; Cheresh DA; Asch E; Seligsohn U
    Blood; 1991 Jan; 77(1):75-83. PubMed ID: 1702031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood leukocytes bind platelet glycoprotein (IIb-IIIa)' but do not express the vitronectin receptor.
    Krissansen GW; Lucas CM; Stomski FC; Elliott MJ; Berndt MC; Boyd AW; Horton MA; Cheresh DA; Vadas MA; Burns GF
    Int Immunol; 1990; 2(3):267-77. PubMed ID: 1708278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
    Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
    J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils promote venular thrombosis by shaping the rheological environment for platelet aggregation.
    Puhr-Westerheide D; Schink SJ; Fabritius M; Mittmann L; Hessenauer MET; Pircher J; Zuchtriegel G; Uhl B; Holzer M; Massberg S; Krombach F; Reichel CA
    Sci Rep; 2019 Nov; 9(1):15932. PubMed ID: 31685838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
    Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin.
    Wu YP; Bloemendal HJ; Voest EE; Logtenberg T; de Groot PG; Gebbink MF; de Boer HC
    Blood; 2004 Aug; 104(4):1034-41. PubMed ID: 15069014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria.
    Liu CZ; Huang HY; Tsai PJ; Shih MH
    Thromb Res; 2005; 116(2):145-55. PubMed ID: 15907530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
    Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
    J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
    Coller BS; Seligsohn U; West SM; Scudder LE; Norton KJ
    Blood; 1991 Nov; 78(10):2603-10. PubMed ID: 1726706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH; Wall CD; White MM; Jennings LK
    Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell adhesion domain in plasma vitronectin is cryptic.
    Seiffert D; Smith JW
    J Biol Chem; 1997 May; 272(21):13705-10. PubMed ID: 9153222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells.
    May AE; Kälsch T; Massberg S; Herouy Y; Schmidt R; Gawaz M
    Circulation; 2002 Oct; 106(16):2111-7. PubMed ID: 12379582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet HDL(3) binding sites are not related to integrin alpha(IIb)beta(3) (GPIIb-IIIa).
    Pedreño J; de Castellarnau C; Masana L
    Atherosclerosis; 2001 Jan; 154(1):23-9. PubMed ID: 11137079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.